Michelle Bellas Romariz Gaudie Ley

Michelle Bellas Romariz Gaudie Ley

Biomedical Engineering, University of Miami, Coral Gables, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2018 in Ciência e Natura
Verified
Journal Article
Open access
PDF file
MLMarcelo Lippi
Marcelo Lippi
Michelle Bellas Romariz Gaudie LeyMichelle Bellas Romariz Gaudie Ley
Michelle Bellas Romariz Gaudie Ley
GMGabriel de Pinna Mendez
Gabriel de Pinna Mendez
RJRicardo Abranches Felix Cardoso Junior
Ricardo Abranches Felix Cardoso Junior
Population growth, especially in urban areas, combined with modern levels of social consumption, contribute for a significant increase of waste production. Among the environmental impacts resulting from the operation of landfills, the generation of leachate is certainly one of the most significant and most difficult to control. The composition of leachate is complex and varied; it contains physicochemical and biological characteristics that are aggressive to the soil, water resources, fauna and flora. The technical and operational difficulties to handle it are challenges for waste managers. There are several methods to treat leachate which are widely debated in the literature, each having advantages and disadvantages. The present paper has the objective of carrying out a bibliographical review of leachate treatment from landfills, addressing the main technologies, as well as discussing their applications, advantages, disadvantages and uncertainties. According to what was studied, the technologies that have been found to have the best practical results and, in general, reach the parameters for treated effluent provided for environmental legislations, are those that use filtering membranes. However, one of the major disadvantages of these processes is the generation of a concentrate, which is normally recirculated in the landfill itself.

13 May 2025 in Cells
Verified
Journal Article
Open access
PDF file
MPMarc Philippon
Marc Philippon
RLRamy Labib
Ramy Labib
Michelle Bellas Romariz Gaudie LeyMichelle Bellas Romariz Gaudie Ley
Michelle Bellas Romariz Gaudie Ley
LKLee D. Kaplan
Lee D. Kaplan
AMArmando J Mendez
Armando J Mendez
Dimitrios KouroupisDimitrios Kouroupis
Dimitrios Kouroupis
Osteoarthritis (OA) remains a leading cause of disability worldwide, with no disease-modifying therapies currently available for treatment. The infrapatellar fat pad (IFP) harbors mesenchymal stem/stromal cells (MSC) with potent immunomodulatory and regenerative properties, making them a promising candidate for OA treatment. A growing body of evidence suggests that the therapeutic effects of MSC are largely mediated by their extracellular vesicles (EVs), which carry bioactive cargo that modulates inflammation and tissue repair. However, optimizing MSC-derived EVs as a cell-free therapeutic approach requires an in-depth understanding of how culture conditions and inflammatory/hormonal priming influence their functional properties. In this study, IFP-MSC were expanded in regulatory-compliant human platelet lysate (HPL) and xeno-/serum-free (XFSF) media and primed with an inflammatory/fibrotic cocktail (TIC) with oxytocin (OXT) to assess the impact on their immunophenotypic profile and EV cargo. The immunophenotype confirmed that TIC+OXT-primed MSC retained key immunomodulatory surface markers, while EV characterization verified the successful isolation of CD63+/CD9+ vesicles. Pathway enrichment analysis of both HPL- and XFSF- TIC+OXT EVs cargo identified key miRNAs associated with immune regulation, tissue repair, and anabolic signaling. Functional assays revealed that TIC+OXT EVs promoted M2-like anti-inflammatory macrophage polarization and exhibited chondroprotective properties in chondrocytes/synoviocytes inflammatory osteoarthritic assay. These findings highlight the therapeutic potential of TIC+OXT-primed IFP-MSC-derived EVs as immunomodulatory and chondroprotective agents, offering a promising strategy for OA treatment through a clinically viable, cell-free approach.

24 February 2026 in Cells
Verified
Journal Article
Open access
PDF file
Michelle Bellas Romariz Gaudie LeyMichelle Bellas Romariz Gaudie Ley
Michelle Bellas Romariz Gaudie Ley
HTH Thomas Temple
H Thomas Temple
AJAlicia R Jackson
Alicia R Jackson
Thomas BestThomas Best
Thomas Best
Dimitrios KouroupisDimitrios Kouroupis
Dimitrios Kouroupis
GDGianluca D’Ippolito
Gianluca D’Ippolito
Marrow-isolated adult multilineage inducible (MIAMI) cells are a subpopulation of mesenchymal stem/stromal cells (MSC) with enhanced self-renewal, multilineage plasticity, and anti-inflammatory properties, suggesting that their extracellular vesicles (MIA-EVs) may confer advantages over conventional MSC-EVs. MIAMI cells were transcriptionally profiled and expressed regenerative markers, including PDGFRB, CDX2, and TERT. We report the first successful isolation and characterization of MIA-EVs. EVs were isolated by ultracentrifugation and characterized by nanoparticle tracking analysis, transmission electron microscopy, flow cytometry, and surface markers. Cargo analysis identified growth factors (IGFBP-1, HGF, VEGF-D) and 19 highly expressed miRNA targeting survival, regenerative, and immune regulatory pathways. MIA-EVs were efficiently internalized, enhanced keratinocyte wound closure and suppressed osteosarcoma proliferation in vitro. Conditioned MIA-EVs reshaped pathway weighting without altering core regulatory identity, as a conserved 15-miRNA backbone persisted across naïve, irradiated, and cytokine-primed states. In contrast, a 9-miRNA core shared with MSC-EVs defined a basal mesenchymal framework, while MIA-EVs expanded regenerative, survival, and immune network connectivity. Similar to embryonic stem cell (ESC)-EVs, both MIA- and cytokine-primed EVs promoted M2 macrophage polarization, selectively upregulating IL1R2 and PPARG/STAT1, respectively. Meanwhile, MSC-EVs induced heterogeneous responses. These findings establish MIA-EVs as a conditioning-resistant, systems-regulated, cell-free platform with regenerative, immunomodulatory, and cytoprotective potential under hostile microenvironments.

Verified
Journal Article
Open access
PDF file
CCCole Conforti
Cole Conforti
DKDarden Wood Kimbrough
Darden Wood Kimbrough
NPNeep Patel
Neep Patel
Michelle Bellas Romariz Gaudie LeyMichelle Bellas Romariz Gaudie Ley
Michelle Bellas Romariz Gaudie Ley
JFJose Medina Flores
Jose Medina Flores
Dimitrios KouroupisDimitrios Kouroupis
Dimitrios Kouroupis
Endometrial tissue-derived mesenchymal stem/stromal cells (eMSCs) have potential therapeutic properties partially exerted via their secreted extracellular vesicles (EVs). eMSC-EVs contain cargos with regenerative and immunomodulatory properties. Specifically, the miRNA profile of CD146High eMSC-EVs has been shown to promote anti-inflammatory M2 macrophage polarization in vitro. Herein, we aimed to characterize the lncRNA profile of CD146High and CD146Low eMSC-EVs and further assess their immunomodulatory and anabolic therapeutic function in osteoarthritis (OA). We hypothesized that the CD146High eMSC-EVs lncRNA profile is enriched with potent anti-inflammatory and pro-anabolic cartilage effects when compared to the CD146Low eMSC-EVs lncRNA profile. Human endometrial tissue was collected, and the eMSCs were magnetically sorted to yield the CD146High and CD146Low eMSC subpopulations. The eMSC-EVs were isolated via ultracentrifugation and CD63 magnetic immunoselection methods and characterized by nanosight and flow cytometry analyses. Our results showed that CD146High eMSC-EVs display an lncRNA profile with both anabolic and catabolic features, exerting a more dynamic effect on chondrocyte gene expression than CD146Low eMSC-EVs, suggesting a potential benefit of using CD146High eMSC-EVs to attenuate the negative effects of inflammation in OA. CD146High eMSC-EVs also demonstrated greater endothelial repair capacity under inflammatory stress. In conclusion, cell-free CD146High eMSC-EV has therapeutic potential through its protective anti-inflammatory effects, warranting further pre-clinical investigation.

3 February 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
Michelle Bellas Romariz Gaudie LeyMichelle Bellas Romariz Gaudie Ley
Michelle Bellas Romariz Gaudie Ley
KGKarina Galoian
Karina Galoian
DMDaniel A. Martinez
Daniel A. Martinez
APArianna Patel
Arianna Patel
RTReanna Thomas
Reanna Thomas
Dimitrios KouroupisDimitrios Kouroupis
Dimitrios Kouroupis
Soft tissue sarcoma remains challenging to treat due to its heterogeneity, stemness-associated survival programs, and resistance to conventional therapies. Extracellular vesicles (EVs) mediate tumor–stroma communication, yet how stemness-targeted therapies reshape EVs-associated miRNAs networks remains unclear. This study profiled EVs miRNAs cargo from infrapatellar fat pad mesenchymal stem/stromal cells (IFP-MSCs) and sarcoma cells (SCs) under basal conditions and following treatment with a synthetic tyrosine peptide analog (TPA). EVs were isolated, characterized, and subjected to miRNAs profiling and pathway enrichment analyses. TPA induced ≥2-fold regulation of 182 miRNAs, including 49 upregulated and 24 downregulated in IFP-MSC-EVs and 86 upregulated and 23 downregulated in SC-EVs. A conserved core of 149 miRNAs (67.1%) was shared across all EVs groups. Abundant species included miR-3960 and miR-21-5p, while TPA reduced tumor-associated miRNAs such as miR-1246 (~10-fold decrease in IFP-MSC-EVs). Pathway enrichment revealed consistent targeting of cancer, MAPK, Wnt, TGF-β, and immune signaling pathways, with modest increases in mapped gene coverage following TPA treatment. In silico analysis identified distinct EVs miRNA–gene interaction profiles, with VEGFA emerging as a recurrent predicted target. These results demonstrate that stemness-targeted modulation quantitatively reprograms EVs miRNA cargo in a cell-type-dependent manner, reshaping vesicle-mediated signaling networks in sarcoma.

4 March 2021 in Ciência e Natura
Verified
Journal Article
Open access
PDF file
MLMarcelo Lippi
Marcelo Lippi
Michelle Bellas Romariz Gaudie LeyMichelle Bellas Romariz Gaudie Ley
Michelle Bellas Romariz Gaudie Ley
GMGabriel de Pinna Mendez
Gabriel de Pinna Mendez
RJRicardo Abraches Felix Cardoso Junior
Ricardo Abraches Felix Cardoso Junior
The different methodologies of leachate treatment are widely debated in the literature, promoting a great discussion among the scientific and academic community on the most efficient and propitious methods. Membrane treatment processes, especially Reverse Osmosis (RO), stand out as the best solution. The RO has pollutant removal rates higher than 99%, with operational cost and complexity competitive with other technologies. Its main disadvantage is the concentrated residue generated in the process that covers about 30% of the volume of leachate entering the system. Its recirculation in the body of the landfill arises as an alternative of low destination cost. Its effectiveness is directly related to the method of recirculation along the geological, climatological, technical and operational conditions of the landfills. Although already widespread, the treatment or destination of the concentrate requires a greater technological assertion. Further research is needed on the recirculation methods of the concentrate and its medium and long-term effects on leachate, settlement and landfills after care period. It is important to make a comparative analysis of landfills with similar characteristics, one with and another without recirculation of the concentrate. Alternatives to treat the concentrate are also of great interest whether they are economically viable in real scale.